ACTIVE

Stoffels IMC

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result854,8 k €-47,8 %over 1 year
Gross margin1,6 M €-35,6 %over 1 year
Equity4,3 M €+25,0 %over 1 year
Workforce1,2 ETP-29,4 %over 1 year

Identity

Source · BCE/KBO

Stoffels IMC is a Private limited company incorporated in 2022. Its main activity is: Management consultancy activities. Its registered office is in Bruxelles. It employs on average 1,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0780.918.294
Incorporation
26/01/2022
Legal form
Private limited company
Registered office
Place des Barricades 13
1000 Bruxelles · BruxellesSee on map
Contributed capital
50 000,00 €
Latest accounts
31/12/2025
Average workforce
1,2 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin1,6 M €2,5 M €1,8 M €655,3 k €
EBITDA1,4 M €2,2 M €1,5 M €572,9 k €
Operating result1,4 M €2,2 M €1,5 M €572,9 k €
Net result854,8 k €1,6 M €1,2 M €495,8 k €
Balance sheet
Equity4,3 M €3,4 M €7 M €5,8 M €
Total assets4,5 M €4,2 M €7,9 M €6,1 M €
Cash875,2 k €2,3 M €1,1 M €83,9 k €
Debts229,3 k €840,9 k €866,8 k €309,9 k €
Other
Workforce1,2 ETP1,7 ETP2,0 ETP2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriod
Katelijne Bruurs
Directorsince 01/09/2022
Paul Stoffels
Directorsince 25/01/2022

Other companies at this address

Place des Barricades 13 1000 Bruxelles
CompanyCBE no.
ALBA HOLDING● Active
1038.846.046
ARMED CELL THERAPEUTICS● Active
1039.592.451
BIOQUBE FACTORY FUND I● Active
0747.784.678
Bioqube Factory Fund II Partnership● Active
1016.717.178
Bioqube Factory Fund II Privak● Active
1016.385.497
Domein van Vorselaar● Active
0423.793.790
EDWIN VERMULST● Active
0862.424.030
Fibrocor Therapeutics Europe● Active
1025.566.152
MERISANT EUROPE● Active
0471.239.064
Orgues De Facto● Active
0763.798.685
PETER KUGEL● Active
0607.848.520
Société Coopérative pour le Développement Industriel en Afrique● Liquidation
0400.488.749
Société des Habitations à Bon Marché● Liquidation
0403.363.117
VIPOWA● Active
0886.120.437
VVGB 2016● Active
0654.806.418
VVGB Advocaten fv● Active
0525.904.504

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202325/01/2022
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months12 months
Filing date17/07/202608/07/202518/07/202407/07/2023
General meeting23/06/202616/06/202529/06/202430/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202523/06/202617/07/2026DutchPDF
Abridged model31/12/202416/06/202508/07/2025DutchPDF
Abridged model31/12/202329/06/202418/07/2024DutchPDF
Abridged model31/12/202230/06/202307/07/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriod
Katelijne Bruurs
Directorsince 01/09/2022
Paul Stoffels
Directorsince 25/01/2022

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates11/06/2024
    ONTSLAGEN - BENOEMINGEN - DIVERSEN
    PDF
  • Other01/06/2023
    DIVERSEN
    PDF
  • Mandates17/10/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares27/04/2022
    KAPITAAL - AANDELEN
    PDF
  • Other28/01/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF
  • Other28/01/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings4 filings
Mandates
Katelijne Bruurs
Paul Stoffels
20222023202420252026
Stoffels IMC
Place des Barricades 13, 1000 Brussels
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Place des Barricades 13, 1000 BrusselsCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00312974

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Stoffels IMCCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00312974

Events

  1. 2025
    Annual accounts 2025854,8 k €↓
  2. 2024
    Annual accounts 20241,6 M €↑
  3. 2023
    Annual accounts 20231,2 M €↑
  4. 2022
    Annual accounts 2022495,8 k €
  5. 26/01/2022
    IncorporationPrivate limited company